Semisynthesis and Biological Evaluation of Xanthone Amphiphilics as Selective, Highly Potent Antifungal Agents to Combat Fungal Resistance

• Published in: Journal of medicinal chemistry Vol. 60; no. 24; pp. 10135 - 10150
• Main Authors: Lin, Shuimu, Sin, Wan Ling Wendy, Koh, Jun-Jie, Lim, Fanghui, Wang, Lin, Cao, Derong, Beuerman, Roger W, Ren, Li, Liu, Shouping
• Format: Journal Article
• Language: English
• Published: WASHINGTON American Chemical Society 28.12.2017; Amer Chemical Soc
• Subjects: Chemistry, Medicinal; Life Sciences & Biomedicine; Pharmacology & Pharmacy; Science & Technology; GARCINIA-MANGOSTANA; DEFENSE; INFECTIONS; CANDIDA-ALBICANS; IN-VIVO EFFICACY; ALPHA-MANGOSTIN; KERATITIS; ANTIMICROBIAL PEPTIDES; DERIVATIVES; MEMBRANE-TARGETING PROPERTIES
• ISSN: 0022-2623; 1520-4804
• DOI: 10.1021/acs.jmedchem.7b01348

New efficient antifungal agents are urgently needed to treat drug-resistant fungal infections. Here, we designed and synthesized a series of cationic xanthone amphiphilics as antifungal agents from natural α-mangostin to combat fungal resistance. The attachment of cationic residues on the xanthone scaffold of α-mangostin resulted in interesting antifungal agents with a novel mode of action. Two lead compounds (1 and 2) showed potent antifungal activity against a wide range of fungal pathogens, including drug-resistant Candida albicans, Aspergillus, and Fusarium strains and low cytotoxicity and hemolytic activity against mammalian cells. Both compounds can kill fungus rapidly by directly disrupting fungal cell membranes and avoid developing drug resistance. Additionally, compound 1 exhibited potent in vivo antifungal activity in the murine model of fungal keratitis. To our knowledge, membrane-targeting xanthone-based antifungals have not been reported previously. These results demonstrated that compounds 1 and 2 may be promising candidates for treating drug-resistant fungal infections.